Clinical trial reveals dapagliflozin’s impact on heart failure and type 2 diabetes management

Researchers conducted a clinical trial on the effects of dapagliflozin on the urinary albumin-to-creatinine ratio (UACR) in patients with heart failure (HF) and type 2 diabetes mellitus (T2D).

Early life high fructose exposure is associated with increased prevalence of adolescent anxiety disorders

Researchers investigated whether exposure to high fructose in early life directly affects essential microglia function.

September 4, 2023

Australia Becomes the First Country to Prescribe Psychedelics to Treat Depression and PTSD | Psychedelic Spotlight

On Saturday, July 1, 2023, Australia officially became the first country to allow physicians to prescribe MDMA to treat post-traumatic stress disorder (PTSD) and psilocybin

July 3, 2023

RxBenefits Appoints Mark Campbell as Chief Pharmacy Officer

What You Should Know: – RxBenefits, a leading pharmacy benefits optimizer (PBO), has announced the appointment of Mark Campbell, PharmD, as its first Chief Pharmacy

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.